all report title image
  • Published On : Sep 2022
  • Code : CMI3215
  • Industry : Pharmaceutical
  • Pages : 102
  • Formats :

A medical food is specifically formulated for patients, who require medical food as a major part of their dietary supplement during treatment. They are custom-made liquid solutions created with the sole purpose of curing persons suffering from various illnesses. Professionals provide the designed meal to people suffering from various illnesses. It is a specially prepared diet that provides patients with adequate nutrients.

Medical foods are available in different forms such as powders, liquids, and even gum. Moreover, medical foods are more commonly used to treat chronic conditions and diseases through long-term use in an outpatient setting. Manufacturers are developing products for new illness indications, fueling growth of the medical food market. Medical food is specifically tailored to meet the nutritional and metabolic demands of those suffering from a specific illness.

Market Dynamics

Medical foods are also used in the treatment of other gastrointestinal diseases such as diarrhea, constipation, gastroenteritis, peptic ulcer diseases, and colorectal cancer, which is expected to propel market growth over the forecast period. Moreover, the increasing geriatric population suffering from several chronic and neurogenic disorders such as dementia, stroke, multiple sclerosis, and difficulty in swallowing requires specific dietary management, which, in turn, is expected to drive the market growth over the forecast period. For instance in July 2019, Georgetown University entered into a collaboration with National Center for Complementary and Integrative Health (NCCIH), University of Maryland, a United States government agency which explores complementary and alternative medicine, initiated early phase 1 clinical trial to demonstrate the mechanisms of preventing antibiotic-associated diarrhea and the role of probiotics.

Key features of the study:

  • This report provides in-depth analysis of the U.S. Medical Foods market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the U.S. Medical Foods market  based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Enterome SA, Yakult Honsha Co., Ltd., Abbott, ExeGi Pharma, LLC, VSL Pharmaceuticals, Inc., Entera Health, Inc., Meiji Holdings Co., Ltd., Danone, and Nestlé S.A.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The U.S. Medical Foods market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the U.S. Medical Foods market

Detailed Segmentation:

  • U.S. Medical Foods Market, By Food Type:
    • Prebiotics
    • Probiotics
      • Probiotic Foods
      • Probiotic Supplements
    • Food Supplements
  • U.S. Medical Foods Market, By Disease Indication:
    • Inflammatory Bowel Disease
      • Ulcerative Colitis
      • Cohn’s Disease
    • Irritable Bowel Syndrome
    • Others
  • U.S. Medical Foods Market, By Distribution Channel:
    • Hospitals
    • Retail Channel
    • Online Channel
  • Company Profiles
    • Enterome SA*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Yakult Honsha Co., Ltd.
    • Abbott
    • ExeGi Pharma, LLC.
    • VSL Pharmaceuticals, Inc.
    • Entera Health, Inc.
    • Meiji Holdings Co., Ltd.
    • Danone
    • Nestlé S.A.

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Food Type
      • Market Snapshot, By Disease Indication
      • Market Snapshot, By Distribution Channel
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Recent Developments
    • Acquisitions and Partnerships Scenario
    • Technology Overview
    • Recent Product Launch
    • Epidemiology
    • Major Brand Analysis
    • Regulatory Scenario
    • PEST Analysis
  4. U.S. Medical Foods Market- Impact of Coronavirus (Covid-19) Pandemic
    • Overall Impact
    • Impact on Supply and Demand
    • COVID-19 Impact on the market
  5. U.S. Medical Foods Market, By Food Type, 2017 – 2030, (US$ Million)
    • Overview
      • Market Share Analysis, 2022 and 2030 (%)
      • Y-o-Y Growth Analysis, 2017 – 2030
      • Segment Trends
    • Prebiotics
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Probiotics
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
        • Probiotic Foods
        • Probiotic Supplements
    • Food Supplements
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)  
  6. U.S. Medical Foods Market, By Disease Indication, 2017 – 2030, (US$ Million)
    • Overview
      • Market Share Analysis, 2022 and 2030 (%)
      • Y-o-Y Growth Analysis, 2017 – 2030
      • Segment Trends
    • Inflammatory Bowel Disease
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
        • Ulcerative Colitis
        • Cohn’s Disease
    • Irritable Bowel Syndrome
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)  
  7. U.S.  Medical Foods Market, By Distribution Channel, 2017 – 2030, (US$ Million)
    • Overview
      • Market Share Analysis, 2022 and 2030 (%)
      • Y-o-Y Growth Analysis, 2017 – 2030
      • Segment Trends
    • Hospitals
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Retail channel
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Online Channel
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
  8. Competitive Landscape
    • Enterome SA
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Yakult Honsha Co., Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Abbott
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • ExeGi Pharma, LLC.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • VSL Pharmaceuticals, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Entera Health, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Meiji Holdings Co., Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Danone
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Nestlé S.A.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
  9.  Section
    • Research Methodology
    • About Us

*Browse 27 market data tables and 31 figures on "Medical Foods Market” – U. S. forecast to 2030

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo